Monday, October 24, 2016
4G Clinical, a clinical trials software company focused on simplifying and accelerating the drug development process, has raised $5 million in Series A1 financing led by Boston-based Schooner Capital. Combined with $2.5 million that was announced in January, this latest round of financing brings 4G’s Series A funding total to $7.5 million. The additional funding will be used to support company operations, further product development and support early marketing of Prancer, the company’s fourth generation Randomization and Trial Supply Management (RTSM) offering.
Science 37, a technology-enabled clinical research company, has completed a $31 million Series B financing. Science 37 is reimagining clinical research by bringing clinical trials to people’s homes, which unlocks access to those beyond a geographical barrier. The investment will help the company grow operations, further develop its novel technology platform and continue to expand into new therapeutic areas.
NNIT, a global provider of IT services and consultancy, has announced a worldwide partnership with SAP SE, the market leader in enterprise application software, to market leading solutions supporting regulatory compliance for Identification of Medicinal Products (IDMP) within the pharmaceutical industry.
NICE and NHS England have launched a 12 week consultation on changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal (TA) and Highly Specialised Technologies (HST) programs.
23andMe, a personal genetics company, has announced a new grant from the NIH, for the creation of a genetic resource for health research in African Americans that could improve the understanding of diseases in minority populations.
Veeva Systems has introduced Veeva Vault EDC and Veeva Vault eSource, the first applications for clinical data management on a single cloud platform. Together with Vault CTMS, Vault eTMF, and Vault Study Startup, Veeva is expanding the Veeva Vault Clinical Suite, the industry’s only suite of unified cloud applications to streamline clinical operations and data management, from study startup to archive.
ClinCapture has opened a new local office on West Broadway in New York, NY. The expansion of the California-based EDC vendor to New York City allows for ClinCapture to better serve its East Coast customers as the company continues to grow. Headquartered in San Francisco, CA, ClinCapture empowers its customers to build their own studies, lower their clinical trials costs, and streamline their data capture processes.
DelSiTech, a Finnish drug delivery technology and drug development company, and Bayer have signed a collaboration and technology license agreement for the worldwide application of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology.
Clinerion is releasing a new version of its Patient Recruitment System (PRS), adding speed, a library of protocol statements, collaboration tools and an updated look-and-feel.